Three Engineering Professors Selected for SYNERGY Translational Pilot Awards
April 17, 2015 | Dartmouth SYNERGY
The SYNERGY Translational Pilot Program facilitates collaborative translational research studies across Dartmouth and affiliated health centers and communities.
Beichen Dai '16 was awarded The Mazilu Engineering Research Fellowship for 2015–2016.
Dartmouth investigators led by Karl Griswold are engineering antibacterial enzymes to target the prevalent drug-resistant bacterium Staphylococcus aureus.
“Firefly” Mechanism Makes Cancer Studies More Efficient, Less Expensive
April 1, 2015 | NCCC
The mechanism that makes fireflies glow through a process called bioluminescence can be used to study tumor response to therapy as well.
Researchers Use Nanoparticles to Selectively Target Tumor Cells in Two Cancer Models
March 25, 2015 | NCCC
Professor Karl Griswold: "The ultimate utility of anti-cancer nanoparticle technologies will depend in large part on their capacity to selectively home to cancer cells."
Immunomagnetic Assay On-a-Chip Captures, Analyzes Circulating Tumor Cells
March 24, 2015 | NCCC
Professor John Zhang led a team of bioengineers to find a new way to quantify rare tumor markers that allow oncologists to make prognoses and select therapies.
Researchers, including Dartmouth engineering professors Jonathan Elliott and Brian Pogue, have reduced the barriers for late stage pancreatic cancer benefiting from photodynamic therapy.
Flower-shaped magnetic nanoparticles may help destroy deep-seated cancer cells
March 12, 2015 | Materials Research Society
The Dartmouth magnetic nanoparticles form flower-like aggregates which helps them to generate cancer-killing heat while under the influence of low alternating magnetic fields.
Flower-like Magnetic Nanoparticles Target Difficult Tumors
March 3, 2015 | AIP Publishing
Dartmouth/Thayer researchers aim to treat deep-seated tumors by using a flower-shaped magnetic nanoparticle capable of reaching deeper within the human body.
Cherenkov Effect Improves Radiation Therapy for Patients with Cancer
February 25, 2015 | NCCC
Investigators from Dartmouth's Norris Cotton Cancer Center, led by engineering professor Brian W. Pogue, published how parts of the blue light known as the Cherenkov Effect can be measured and used to make therapies safer and more effective.